radiolabel
isatin
sulfonamid
inhibitor
f
potenti
pet
radiotrac
noninvas
imag
apoptosi
radiolabel
mechan
studi
c
nmr
esim
comput
calcul
found
high
electrophil
carbonyl
group
isatin
ring
serv
trap
f
fluorid
respons
failur
radiolabel
via
nucleophil
substitut
mesyl
group
f
fluorid
treat
strong
base
open
isatin
ring
complet
form
isatin
intermedi
lost
abil
trap
f
fluorid
therebi
allow
displac
mesyl
group
afford
flabel
isatin
f
convert
isatin
f
effici
acid
condit
ringopen
reclosur
isatin
ring
basic
acid
condit
confirm
revers
phase
hplc
analysi
esim
c
nmr
studi
comput
studi
model
compound
also
support
propos
mechan
similarli
ringopen
reclosur
method
use
success
synthesi
c
label
isatin
sulfonamid
analogu
c
micropet
imag
studi
use
c
fa
liver
apoptosi
model
demonstr
retain
activ
target
organ
liver
treat
mice
increas
activ
liver
verifi
fluorometr
enzym
assay
therefor
studi
provid
use
method
radiosynthesi
isatin
deriv
radiotrac
pet
spect
studi
c
potenti
pet
radiotrac
noninvas
imag
apoptosi
molecular
imag
visual
character
measur
biolog
process
molecular
cellular
level
human
live
system
positron
emiss
tomographi
pet
one
vivo
imag
techniqu
use
molecular
imag
use
frequent
clinic
research
field
high
sensit
minim
physiolog
effect
pet
tracer
good
spatial
resolut
eas
accur
quantif
one
import
applic
molecular
imag
studi
program
cell
death
apoptosi
molecular
level
apoptosi
critic
normal
develop
function
multicellular
organ
common
univers
mechan
cell
death
abnorm
regul
cellular
death
via
apoptosi
believ
play
key
role
varieti
human
diseas
addit
benefici
effect
chemotherapi
radiotherapi
antitumor
therapi
attribut
activ
apoptot
process
therefor
develop
noninvas
imag
procedur
studi
process
apoptosi
varieti
diseas
state
monitor
abil
drug
treatment
either
induc
halt
apoptosi
would
tremend
valu
research
clinic
commun
one
commonli
use
agent
far
imag
apoptosi
vivo
base
annexin
v
kda
protein
bind
select
high
affin
phosphatidylserin
protein
extern
earli
stage
apoptosi
activ
annexin
v
label
differ
radioisotop
pet
singl
photon
emiss
comput
tomographi
spect
studi
tclabel
annexin
v
use
spect
show
promis
result
undergo
clinic
trial
howev
sinc
extern
phosphatidylserin
also
occur
necrosi
radiolabel
annexin
v
specif
imag
apoptosi
vivo
altern
strategi
visual
cell
tissu
undergo
apoptosi
use
peptid
small
molecul
direct
toward
enzym
intrins
biochem
pathway
apoptosi
enzym
respons
regul
execut
apoptosi
caspas
exist
inact
zymogen
procaspas
cytosol
becom
activ
cell
receiv
apoptot
signal
caspas
activ
earli
process
apoptosi
known
initi
caspas
function
initi
caspas
activ
execution
caspas
respons
proteolyt
cleavag
protein
necessari
cellular
function
cellular
apoptosi
initi
via
two
differ
pathway
extrins
intrins
sinc
pathway
converg
level
activ
immunohistochem
stain
activ
provid
unambigu
marker
apoptosi
number
isatin
sulfonamid
analogu
report
high
inhibit
potenc
execution
caspas
high
select
caspas
one
isatin
sulfonamid
analogu
benzyl
label
f
evalu
biodistribut
studi
cycloheximid
liver
injuri
model
rat
wellestablish
murin
model
chemicallyinduc
apoptosi
biodistribut
studi
f
reveal
higher
uptak
liver
spleen
cycloheximidetr
rat
compar
untreat
control
rat
also
report
first
micropet
imag
studi
directli
measur
activ
tissu
undergo
apoptosi
use
f
pet
radiotrac
given
central
import
apoptosi
varieti
diseas
state
well
new
drug
develop
develop
f
promis
radiotrac
pet
imag
apoptosi
signific
studi
apoptosi
vivo
requisit
radiolabel
reaction
usual
take
place
via
nucleophil
substitut
good
leav
group
mesyl
tosyl
triflat
basic
condit
f
label
methyl
use
c
ch
presenc
base
c
label
label
reaction
differ
normal
chemic
synthesi
half
live
f
min
c
min
short
limit
reaction
time
therefor
fast
reaction
time
simpl
procedur
requir
secondli
tracer
amount
radioact
isotop
f
fluorid
c
ch
present
react
larg
excess
substrat
label
reaction
benefit
larg
amount
substrat
increas
rate
reaction
time
amount
reactiv
impur
reactiv
function
group
substrat
might
react
f
fluorid
c
ch
gener
sideproduct
slow
even
stop
desir
radiolabel
reaction
varieti
reaction
take
place
isatin
ring
isatin
analogu
one
reaction
nucleophil
attack
carbonyl
carbon
isatin
ring
warhead
group
crucial
inhibit
isatin
sulfonamid
analogu
although
isatin
sulfonamid
analogu
exhibit
good
potenc
inhibit
prepar
radiolabel
isatin
sulfonamid
analogu
f
c
pet
imag
limit
difficulti
radiolabel
f
c
use
standard
method
order
improv
synthesi
compound
sought
better
understand
radiolabel
reaction
examin
mechan
experiment
model
studi
furthermor
relat
isatin
deriv
report
drug
candid
inhibit
sar
coronaviru
proteas
proteas
carboxylesteras
revers
transcriptas
also
exhibit
cytotox
cancer
cell
vitro
studi
could
provid
use
method
synthes
isatin
deriv
radiotrac
pet
spect
studi
report
radiolabel
reaction
nbenzylisatin
sulfonamid
analogu
f
c
mechan
model
studi
label
reaction
evalu
c
compound
vivo
micropet
imag
studi
fa
liver
injuri
model
mice
synthes
standard
compound
precursor
f
label
c
label
shown
scheme
isatin
nitrogen
alkyl
treatment
sodium
hydrid
dmf
min
follow
addit
variou
alkyl
halid
give
compound
respect
compound
heat
reflux
silver
methanesulfon
silver
ptoluenesulfon
ch
cn
gener
precursor
precursor
prepar
hydrolysi
sodium
hydroxid
aqueou
methanol
synthesi
precursor
carbonyl
group
first
protect
reflux
benzen
use
ptoluenesulfon
acid
catalyst
give
alkyl
bromid
chlorid
give
compound
respect
precursor
prepar
procedur
method
synthesi
f
summar
scheme
first
precursor
convert
complet
isatin
salt
treatment
strong
base
bu
noh
k
co
kryptofix
k
order
avoid
trap
effect
due
carbonyl
group
isatin
nucleophil
substitut
reaction
took
place
standard
label
condit
replac
mesyl
tosyl
group
afford
f
label
isatin
salt
high
yield
convert
quickli
f
high
yield
hcl
microwav
irradi
f
confirm
revers
phase
hplc
coelut
nonradioact
standard
synthesi
time
min
label
yield
high
chemic
radiochem
puriti
good
specif
activ
high
mcimmol
n
altern
f
synthes
carbonylprotect
mesyl
precursor
follow
hydrolysi
use
n
hcl
similar
manner
c
synthes
shown
scheme
reaction
provid
f
c
high
yield
high
specif
activ
suitabl
use
molecular
imag
studi
apoptosi
typic
procedur
howev
label
reaction
mesyl
precursor
use
standard
method
afford
either
label
product
polar
product
low
yield
accord
tlc
hplc
analysi
interestingli
precursor
first
treat
equival
dri
bu
noh
label
reaction
took
place
effici
form
polar
product
high
yield
could
convert
desir
product
f
gradual
room
temperatur
quickli
elev
temperatur
acid
condit
result
suggest
f
fluorid
displac
mesyl
group
directli
displac
mesyl
group
intermedi
form
basic
condit
propos
mechan
observ
f
label
reaction
shown
scheme
term
nucleophil
addit
isatin
ring
nucleophil
h
oh
f
add
carbonyl
carbon
easili
form
correspond
speci
revers
reaction
howev
oh
group
also
attack
carbonyl
carbon
result
open
isatin
ring
reaction
irrevers
basic
condit
therefor
isatin
might
exist
differ
form
solut
revers
hydrat
form
irrevers
ringopen
form
depend
ph
solut
solvent
use
report
exist
isatin
hydrat
form
ratio
nmr
aqueou
solut
hydrat
form
suggest
hplc
peak
front
observ
revers
phase
hplc
chromatographi
use
ch
cn
water
ph
solvent
peak
front
due
equilibrium
isatin
polar
hydrat
form
result
interact
water
hplc
solvent
peak
front
suppress
addit
methanol
hplc
solvent
system
format
hydrat
form
corrobor
high
electrophil
isatin
ring
carbon
case
order
distinguish
intermedi
involv
follow
label
reaction
c
nmr
studi
carri
sampl
condit
simul
label
reaction
c
chemic
shift
carbonyl
carbon
around
ppm
hydrat
form
ppm
ringopen
form
dmso
precursor
treat
equival
bu
noh
water
clean
format
ringopen
product
isatin
observ
base
observ
new
set
c
nmr
peak
form
complet
disappear
chemic
shift
carbonyl
carbon
shift
ppm
ppm
chemic
shift
expect
ringopen
isatin
form
c
nmr
peak
around
ppm
carbonyl
carbon
hydrat
form
observ
exampl
ppm
similarli
nbenzyl
isatin
use
model
studi
shift
ppm
ppm
ringopen
isatin
form
support
inform
figur
therefor
intermedi
like
involv
label
reaction
ringopen
isatin
form
speci
label
also
attempt
studi
format
fluorid
adduct
c
f
nmr
c
nmr
studi
reaction
mixtur
bu
nf
dmso
indic
gradual
format
isatin
due
unavoid
oh
h
bu
nf
solut
comparison
control
reaction
ad
signaltonois
ratio
f
nmr
bu
nf
reduc
addit
observ
indic
fast
exchang
fluorid
isatin
observ
support
assumpt
f
fluorid
trap
isatin
carbonyl
group
instead
substitut
mesyl
group
f
label
standard
condit
support
inform
figur
order
evalu
electrophil
isatin
isatin
dft
calcul
perform
use
order
compar
reactiv
carbon
toward
nucleophil
attack
calcul
carri
simplifi
isatin
precursor
analogu
obtain
nucleophil
reactiv
fukui
function
ff
frontier
electron
theori
fukui
function
wide
use
local
densiti
function
descriptor
model
chemic
reactiv
site
select
atom
highest
ff
highli
reactiv
compar
atom
molecul
confirm
theoret
calcul
carbon
simplifi
precursor
highest
electrophil
molecul
isatin
ring
open
electrophil
lower
tremend
convert
isatin
form
reactiv
also
decreas
consider
hydrat
form
reactiv
carbon
attach
mesyl
group
com
undergo
chang
good
agreement
propos
radiolabel
mechan
label
mechan
elucid
amount
k
co
use
label
reaction
effect
water
reaction
yield
studi
k
co
use
label
reaction
found
mg
k
co
need
order
obtain
high
yield
label
product
tabl
entri
less
mg
k
co
use
incorpor
initi
microwav
irradi
k
co
k
dmso
ad
yield
increas
compar
valu
mg
k
co
use
tabl
entri
f
fluorid
presenc
k
k
co
dri
care
yield
low
understand
k
co
k
weaker
base
bu
noh
nt
provid
oh
absenc
water
open
isatin
ring
therefor
k
co
use
base
label
reaction
need
longer
reaction
time
trace
amount
h
open
isatin
ring
complet
order
avoid
trap
effect
carbonyl
group
normal
water
exclud
label
reaction
water
solvat
f
fluorid
reduc
nucleophil
lower
reactiv
result
failur
nucleophil
substitut
exampl
isatin
precursor
treat
wet
bu
noh
low
yield
label
product
obtain
tabl
entri
comparison
precursor
treat
dri
bu
noh
tabl
entri
therefor
label
reaction
condit
optim
use
larg
amount
k
co
open
isatin
ring
complet
also
consum
trace
amount
water
left
dri
hydrolysi
isatin
nmethyl
isatin
recycl
isatin
studi
studi
nsubstitut
isatin
quit
limit
stabil
nbenzylisatin
toward
base
hydrolysi
expect
better
isatin
nmethyl
isatin
steric
protect
benzyl
substitut
nitrogen
atom
isatin
ring
stabil
enabl
nbenzylisatinsulfonamid
analogu
function
potenti
tracer
imag
activ
vivo
hydrolysi
nbenzylisatinsulfonamid
studi
revers
phase
hplc
esim
accord
hplc
analysi
reaction
mixtur
bu
noh
hydrolyz
isatin
analogu
form
isatin
exclus
quickli
hydrolysi
k
co
k
quick
hydrolysi
nahco
h
slow
neutral
solut
analogu
stabl
isatin
treat
hcl
convert
back
isatin
analogu
gradual
room
temperatur
quickli
heat
microwav
irradi
base
hydrolyz
isatin
analogu
acid
recycl
isatin
purifi
revers
phase
hplc
hplc
purifi
product
analyz
esim
molecular
ion
plu
h
observ
major
peak
hydrolyz
product
esim
togeth
c
nmr
studi
indic
format
isatin
format
isatin
analogu
acid
recycl
isatin
confirm
comparison
retent
time
hplc
ms
spectrum
correspond
isatin
analogu
support
inform
figur
classic
alkyl
hydroxyl
nitrogen
group
nah
commonli
use
base
deproton
use
nalkyl
synthesi
standard
precursor
nbenzylisatin
sulfonamid
howev
c
methyl
c
ch
excess
nah
use
c
label
fail
afford
expect
radiolabel
product
c
led
format
numer
polar
radioact
peak
observ
revers
phase
hplc
circumv
problem
ketal
precursor
prepar
presenc
nah
label
c
ch
dmf
ch
cn
standard
condit
afford
howev
difficult
remov
dioxolan
protect
group
n
hcl
even
microwav
irradi
condit
use
remov
protect
group
f
label
n
hcl
solut
need
remov
dioxolan
group
harsh
hydrolysi
condit
caus
label
result
inconsist
term
radiochem
yield
specif
activ
tabl
ringopen
reclosur
method
use
f
label
also
use
c
label
equival
bu
oh
h
use
treat
low
mg
substrat
open
isatin
ring
exclus
quickli
omethyl
took
place
standard
condit
afford
c
label
isatin
intermedi
convert
c
treatment
n
hcl
method
simpl
yield
high
chemic
radiochem
puriti
good
tabl
therefor
ringopeningreclosur
method
also
use
c
methyl
label
reaction
isatin
analogu
good
label
result
radiolabel
condit
establish
c
evalu
wellcharacter
mous
model
liver
apoptosi
induc
administr
antifa
antibodi
result
massiv
activ
liver
micropet
imag
biodistribut
studi
perform
micropet
imag
result
shown
figur
clearli
retain
activ
liver
fastreat
mice
compar
control
retent
activ
liver
demonstr
timeact
curv
figur
ex
vivo
analysi
liver
illustr
figur
min
differ
liver
uptak
treat
control
mice
howev
min
clearli
increas
tracer
activ
liver
sampl
taken
treat
mice
compar
control
liver
sampl
biodistribut
studi
taken
analyz
activ
fluorometr
enzym
analysi
use
fluorogen
substrat
acdevdamc
biomol
figur
enzym
analysi
verifi
increas
enzymat
activ
treat
anim
correl
find
micropet
imag
biodistribut
studi
sinc
c
competit
inhibitor
bind
activ
form
tissu
undergo
apoptosi
see
expect
retent
tracer
liver
treat
mice
result
obtain
f
suggest
radiolabel
nbenzylisatin
sulfonamid
analogu
potenti
radiotrac
imag
activ
vivo
demonstr
cand
flabel
isatin
analogu
synthes
use
baseacid
ringopeningrecycl
procedur
protect
carbonyl
group
found
high
electrophil
carbonyl
group
isatin
ring
serv
trap
f
fluorid
result
failur
f
radiolabel
typic
condit
therefor
protect
carbonyl
carbon
isatin
analogu
critic
avoid
unwant
nucleophil
attack
synthesi
baseacid
ringopeningrecycl
procedur
prove
highli
effici
method
purpos
util
method
synthes
f
c
label
isatin
analogu
high
chemic
radiochem
puriti
vivo
evalu
c
fa
liver
injuri
apoptosi
model
demonstr
increas
uptak
tracer
treat
anim
verif
activ
fluorometr
enzymat
assay
correl
retain
tracer
enzym
activ
liver
treat
mice
indic
c
benzylisatin
sulfonamid
analogu
inhibitor
potenti
radiotrac
imag
activ
apoptosi
method
describ
paper
applic
radiolabel
isatin
analogu
chemic
obtain
standard
commerci
sourc
use
without
purif
reaction
carri
standard
airfre
moisturefre
techniqu
inert
argon
atmospher
dri
solvent
unless
otherwis
state
flash
column
chromatographi
conduct
use
scientif
adsorb
inc
silica
gel
micron
flash
melt
point
determin
use
meltemp
apparatu
uncorrect
routin
h
nmr
spectra
record
varian
mhz
nmr
spectromet
chemic
shift
report
part
per
million
ppm
downfield
tetramethylsilan
tm
coupl
constant
j
given
hertz
hz
split
pattern
typic
describ
follow
singlet
doublet
triplet
multiplet
f
nmr
spectra
record
mhz
chemic
shift
report
hz
upfield
extern
cfcl
standard
high
resolut
c
nmr
record
varian
uniti
mhz
esim
perform
water
zq
singl
quadrupol
mass
spectromet
equip
electrospray
ioniz
esi
lcm
interfac
element
analys
c
h
n
determin
atlant
microlab
inc
high
perform
liquid
chromatographi
hplc
perform
ultraviolet
detector
oper
nm
wellscintil
nai
tl
detector
associ
electron
radioact
detect
alltech
econosil
mm
semiprepar
column
altech
altima
mm
analyt
column
use
prepar
analysi
respect
nah
mg
mmol
dispers
miner
oil
ad
solut
mg
mmol
dmf
ml
mixtur
stir
min
benzyl
bromid
mg
mmol
ad
mixtur
stir
h
room
temperatur
mixtur
dilut
ethyl
acet
ml
wash
water
ml
satur
nacl
ml
dri
na
evapor
solvent
crude
product
purifi
silica
gel
chromatographi
use
ether
afford
mg
yellow
solid
mp
prepar
accord
procedur
compound
except
use
bromid
purifi
use
hexaneeth
afford
mg
yellow
solid
mp
prepar
accord
procedur
compound
except
use
benzyl
bromid
purifi
use
hexaneeth
afford
mg
yellow
solid
mp
prepar
accord
procedur
compound
except
use
chloromethi
phenyl
acet
purifi
use
hexaneeth
afford
yellow
solid
mp
solut
mg
mmol
agom
g
mmol
ch
cn
ml
reflux
overnight
filtrat
solid
evapor
solvent
crude
product
purifi
silica
gel
chromatographi
use
ether
afford
mg
yellow
solid
mp
prepar
accord
procedur
compound
except
use
agot
purifi
use
hexaneeth
solut
mg
mmol
methanol
ml
water
ml
ad
naoh
mg
mmol
room
temperatur
mixtur
stir
overnight
acidifi
hcl
extract
ethyl
acet
ml
ethyl
acet
wash
water
ml
satur
nacl
solut
ml
dri
na
evapor
ethyl
acet
crude
product
purifi
silica
gel
chromatographi
use
ether
afford
mg
yellow
solid
mp
solut
mg
mmol
ml
benzen
ml
ad
ptoluenesulfon
acid
mg
mmol
mixtur
reflux
h
form
water
remov
azeotrop
distil
wash
satur
na
co
ml
water
ml
satur
nacl
solut
ml
dri
na
evapor
benzen
crude
product
purifi
silica
gel
chromatographi
use
ether
afford
mg
white
solid
mp
prepar
accord
procedur
compound
except
use
bromoethyl
benzyl
bromid
purifi
use
hexaneeth
afford
mg
white
solid
mp
prepar
accord
procedur
compound
except
use
purifi
use
hexaneeth
afford
mg
white
solid
mp
hydroxi
benzyl
indol
sulfonyl
phenoxymethyl
pyrrolidin
prepar
accord
procedur
compound
except
use
purifi
use
hexaneeth
afford
mg
yellow
solid
mp
ml
solidphas
extract
perform
use
water
oasi
hlb
cartridg
previous
rins
methanol
ml
milliq
water
ml
radioact
sampl
appli
cartridg
rins
addit
water
ml
elimin
unreact
fluorid
salt
radiolabel
product
elut
ch
cn
ml
upon
complet
remov
ch
cn
reduc
pressur
residu
taken
ch
cn
ml
methanol
ml
follow
addit
water
ml
hplc
purif
purif
carri
semiprepar
hplc
alltech
econosil
mm
elut
ch
cn
meoh
ammonium
format
buffer
flow
rate
mlmin
uv
nm
radioact
peak
correspond
f
detect
min
accord
radioact
detector
collect
purif
hplc
collect
f
dilut
water
ml
activ
collect
water
classic
seppak
pass
solut
pressur
seppak
wash
water
ml
remov
trace
ch
cn
dri
nitrogen
activ
elut
ethanol
ml
ethanol
solut
use
prepar
final
solut
salin
anim
studi
total
synthesi
time
min
dioxan
f
label
f
fluorid
dri
k
mg
k
co
mg
ch
cn
nitrogen
flow
see
dmso
ad
ml
pyrex
tube
contain
solut
mg
dmso
tube
cap
firmli
reaction
mixtur
heat
microwav
sec
interv
min
n
hcl
ad
cap
tube
heat
microwav
sec
reaction
mixtur
dilut
water
ml
solut
pass
water
oasi
hlb
cartridg
trap
product
product
elut
ch
cn
ml
oasi
cartridg
condens
almost
dryness
reduc
pressur
recondit
ch
cn
ml
meoh
ml
water
ml
hplc
inject
hplc
purif
final
workup
optim
mci
f
fluorid
k
co
solut
ca
dri
ml
pyrex
tube
k
mg
k
co
mg
azeotrop
distil
gentl
stream
nitrogen
success
addit
three
aliquot
ml
ch
cn
solut
mg
anhydr
dmso
ad
insid
tube
cap
firmli
afterward
reaction
mixtur
shaken
well
hand
purpos
open
isatin
ring
point
solut
color
chang
lighter
pale
yellow
heat
microwav
sec
interv
min
irradi
n
hcl
ad
mixtur
cap
tube
heat
microwav
sec
reaction
mixtur
dilut
water
ml
solut
pass
water
classic
seppak
cartridg
trap
product
elut
backflush
ch
cn
ml
meoh
ml
water
ml
hplc
inject
purif
carri
semiprepar
hplc
alltech
econosil
mm
elut
ch
cn
methanol
ammonium
format
buffer
flow
rate
mlmin
uv
nm
radioact
peak
correspond
f
detect
min
accord
radioact
detector
collect
min
per
tube
major
collect
activ
mainli
tube
dilut
water
ml
water
classic
seppak
use
extract
activ
seppak
wash
water
ml
remov
trace
ch
cn
f
elut
backflush
ethanol
portion
ml
total
portion
contain
major
activ
ca
ml
use
final
dose
prepar
total
synthesi
time
min
radiochem
puriti
specif
activityth
radiochem
puriti
f
determin
analyt
hplc
column
alltech
altima
mm
elut
methanol
water
flow
rate
mlmin
uv
nm
f
elut
min
confirm
coelut
nonradioact
standard
analyt
hplc
system
comparison
integr
sampl
uv
signal
calibr
compound
massuv
absorb
curv
specif
activ
determin
end
synthesi
radiochem
puriti
gener
procedur
radiochem
puriti
specif
activ
c
method
f
use
determin
radiochem
puriti
specif
activ
follow
condit
alltech
altima
mm
column
meoh
ammonium
format
buffer
ph
flow
rate
mlmin
uv
nm
retent
time
c
min
built
hand
optim
level
follow
method
thanikaivelan
chelpg
method
util
assign
electron
popul
use
fukui
analysi
femal
balbc
mice
g
inject
intraven
antifa
antibodi
bd
bioscienc
san
jose
ca
inject
c
min
later
micropet
imag
studi
min
imag
acquir
dynam
obtain
transmiss
scan
attenu
correct
region
interest
drawn
left
lobe
liver
avoid
spillov
activ
gallbladd
biodistribut
studi
anim
sacrif
min
min
tracer
inject
liver
remov
weigh
count
beckman
gamma
counter
percent
inject
dose
per
gram
tissu
idg
present
mean
standard
deviat
protein
extract
liver
sampl
obtain
biodistribut
studi
accord
previous
publish
protocol
protein
load
triplic
plate
acdevdamc
substrat
biomol
intern
lp
plymouth
meet
pa
without
inhibitor
acdevdcho
sigmaaldrich
st
loui
mo
assay
buffer
plate
read
everi
min
h
victor
v
micropl
reader
model
perkinelm
fremont
ca
background
fluoresc
subtract
time
point
read
plot
time
linear
regress
perform
linear
portion
curv
within
h
read
determin
slope
rate
enzym
activ
refer
web
version
pubm
central
supplementari
materi
micropet
imag
c
imag
acquir
dynam
min
sum
singl
slice
coron
sum
imag
demonstr
increas
retent
c
treat
anim
confirm
time
activ
curv
gener
volum
interest
green
place
liver
gallbladd
gb
activ
mark
yellow
arrow
ex
vivo
evalu
c
uptak
liver
compar
mice
treat
fa
antibodi
untreat
control
error
bar
indic
standard
deviat
increas
uptak
c
min
treat
group
group
min
group
min
